首页 | 本学科首页   官方微博 | 高级检索  
     

以新霉素抗性基因突变体为筛选标志的真核表达载体的构建
引用本文:高川 朱旭东 周晓巍 于芳 卢柏松 黄培堂. 以新霉素抗性基因突变体为筛选标志的真核表达载体的构建[J]. 生物工程学报, 2002, 18(3): 308-312
作者姓名:高川 朱旭东 周晓巍 于芳 卢柏松 黄培堂
作者单位:1. 北京药物化学研究所,北京,102205
2. 北京生物工程研究所,北京,100071
摘    要:新霉素抗性基因(neo)是真核表达载体的常用筛选标志neo基因编码新霉素磷酸转移酶Ⅱ(NPT Ⅱ),能催化G418、卡那霉素等多种氨基糖苷抗生素分子磷酸化而使之失去抗菌活性。通过对真核表达载体的筛选标志基因neo进行定点突变,以降低NPTⅡ的活性,然后用含neo突变体的真核表达载体pmDNA构建荧光素酶表达质粒,稳定转染CHO-K1细胞,发现表达荧光素酶的阳性细胞比例达到95%,其中高表达细胞集落的筛选率明显高于对照组。

关 键 词:真核表达载体, 突变体, 筛选标志基因
文章编号:1000-3061(2002)03-0308-05
修稿时间:2001-11-01

Construction of Eukaryofic Expression Vector Using Neomycin-resistance Gene Mutant as Selectable Marker
GAO Chuan ZHU Xu-Dong ZHOU Xiao-Wei YU Fang LU Bai-Song HUANG Pei-Tang. Construction of Eukaryofic Expression Vector Using Neomycin-resistance Gene Mutant as Selectable Marker[J]. Chinese journal of biotechnology, 2002, 18(3): 308-312
Authors:GAO Chuan ZHU Xu-Dong ZHOU Xiao-Wei YU Fang LU Bai-Song HUANG Pei-Tang
Affiliation:Institute of Pharmaceutical Chemistry, Beijing 102205, China. g.ch.chuan@263.net
Abstract:Neomycin-resistance gene is widely used as a selectable marker in eukaryotic expression vector. It codes neomycin phosphotransferase II (NPT II) which confers resistance to various aminoglycoside antibiotic such as G418 and kanamycine. In this work, by site-directed mutagenesis the neo gene mutant was obtained. The expression vector pmDNA using the neo gene mutant as selectable marker has been constructed. After inserting interest luciferase gene, the expression plasmid pmDNAluc + was stably transfected CHO-K1 cells. As a result, the expression positive ratio reaches to approximate 95% and the ratio of high expression colonies is apparently higher than the controls.
Keywords:eukaryotic expression vector   mutant   selectable marker gene
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号